Nanotechnology Derived Nanotools in Biomedical Perspectives: An Update

Abstract

Background: In recent years, nanotechnology is gaining more attention of analytical and biomedical researchers. Nanotechnology derived nanotools deal with the nanoscale length size (i.e., 10-9 m). The particles having size below 100 nm displayed improved properties for attaining increased efficacy, better patient compliance, improved biodistribution and site-specific drug delivery. Method: Google, PubMed, Web of Science portals have been searched for potentially relevant literature to get latest developments and updated information related to different aspects of nanotechnology derived nanocarriers including biomedical applications. Results: Available literature demonstrated that nanotechnology-based nanocarriers like liposomes, dendrimers, polymeric micelles, carbon dots, quantum dots, carbon nanotubes, magnetic nanoparticles, silica nanoparticles, silver nanoparticles and gold nanoparticles have enormous potential applications in the pharmaceutical field. The current review focuses on the drug delivery, bioimaging, tissue engineering and therapeutic applications of different nanotools. Besides these, scope and opportunities, as well as the global market scenario of nanotechnology derived nanotools, have also been discussed. The practice of nanotechnology in the arena of medicine will transform the strategies of detection and treatment of a wide range of diseases in the upcoming years.